Cyr61 inhibitors target and modulate the activity of the Cyr61 protein. Cyr61, also known as CCN1, belongs to the CCN (Cyr61/CTGF/Nov) family of matricellular proteins, which are secreted into the extracellular matrix and play multifaceted roles in cellular functions and tissue remodeling. Cyr61 is involved in diverse cellular processes, and its functions are mediated through interactions with various cell surface receptors, such as integrins and heparan sulfate proteoglycans. Upon binding to these receptors, Cyr61 triggers intracellular signaling pathways that modulate cellular responses to extracellular cues. It is an essential regulator of processes like cell adhesion, migration, proliferation, and survival. Additionally, Cyr61 plays a pivotal role in angiogenesis, the formation of new blood vessels from pre-existing ones, which is crucial for tissue growth and repair. Cyr61 inhibitors are specifically designed to disrupt the interactions between Cyr61 and its cellular receptors, disrupting the transmission of intracellular signals that would typically be initiated by Cyr61 binding. By doing so, these inhibitors can interfere with downstream gene expression and cellular responses that are influenced by Cyr61's activities.
The chemical structures of Cyr61 inhibitors may vary significantly, as researchers continually refine and optimize these compounds to enhance their selectivity and efficacy in modulating Cyr61's functions. The exact mechanisms by which Cyr61 inhibitors interact with Cyr61 and inhibit its activity can also differ based on their specific molecular properties. The targeted modulation of Cyr61 activity by these inhibitors has proven to be an invaluable tool in basic research. By using Cyr61 inhibitors, scientists can delve into the intricate regulatory networks that govern various cellular processes, shedding light on the significance of Cyr61 in normal physiological functions. Cyr61 inhibitors represent a specialized chemical class of compounds designed to selectively target Cyr61 and disrupt its interactions with cellular receptors. Through this targeted modulation, these inhibitors offer valuable tools for researchers to investigate the multifaceted roles of Cyr61 in cellular processes, tissue homeostasis, and angiogenesis, contributing to the advancement of knowledge in various fields of cellular biology.
| 제품명 | CAS # | 카탈로그 번호 | 수량 | 가격 | 引用 | RATING |
|---|---|---|---|---|---|---|
NSC 632839 hydrochloride | 157654-67-6 | sc-204138 sc-204138A | 10 mg 50 mg | $119.00 $465.00 | ||
골관절염과 같은 관절 질환에서 연골 분해와 세포 외 기질 리모델링을 감소시켜 COL2A1 발현과 콜라겐 타입 II 합성을 억제합니다. | ||||||
SB-3CT | 292605-14-2 | sc-205847 sc-205847A | 1 mg 5 mg | $102.00 $388.00 | 15 | |
COL2A1 유전자 전사 및 MMP-2/9 활성화를 억제하여 골관절염과 관련된 연골 분해 및 염증 과정을 약화시킵니다. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $158.00 | 6 | |
COL2A1 발현과 전 염증성 사이토카인을 감소시켜 항염 작용을 통해 관절염의 연골 파괴를 완화합니다. | ||||||
Chondroitinase ABC from Proteus vulgaris | 9024-13-9 | sc-507341 | 2 U | $650.00 | ||
아그레칸의 글리코사미노글리칸 사슬을 분해하여 연골 복구 과정에서 COL2A1 회전율과 매트릭스 리모델링을 조절합니다. | ||||||
Heat Shock Protein Inhibitor I | 218924-25-5 | sc-221709 | 5 mg | $97.00 | 5 | |
Hsp70을 간접적으로 억제하여 COL2A1 발현을 감소시키고 관절염 및 기타 콜라겐 관련 질환에 잠재적으로 치료 효과를 제공합니다. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Rho 관련 단백질 키나아제(ROCK)를 차단하여 잠재적으로 COL2A1 합성을 조절하고 섬유증 및 연골 장애를 개선합니다. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Ca2+/칼모둘린 의존성 단백질 키나아제 II(CaMKII)를 억제하여 COL2A1 발현 및 칼슘 의존성 콜라겐 관련 경로를 약화시킵니다. | ||||||
Piperine | 94-62-2 | sc-205809 sc-205809A | 5 g 25 g | $37.00 $146.00 | 3 | |
COL2A1과 염증성 사이토카인을 하향 조절하여 항염증 작용을 통해 관절염의 연골 분해를 완화할 수 있습니다. | ||||||